These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 28827149)

  • 21. In Vitro Enzyme Assays for JmjC-Domain-Containing Lysine Histone Demethylases (JmjC-KDMs).
    Tarhonskaya H; Tumber A; Kawamura A; Schofield CJ
    Curr Protoc Pharmacol; 2018 Mar; 80(1):3.15.1-3.15.12. PubMed ID: 30040204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lysine demethylase 5B (KDM5B): A potential anti-cancer drug target.
    Zheng YC; Chang J; Wang LC; Ren HM; Pang JR; Liu HM
    Eur J Med Chem; 2019 Jan; 161():131-140. PubMed ID: 30343192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
    Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
    BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histone demethylase KDM5B is a key regulator of genome stability.
    Li X; Liu L; Yang S; Song N; Zhou X; Gao J; Yu N; Shan L; Wang Q; Liang J; Xuan C; Wang Y; Shang Y; Shi L
    Proc Natl Acad Sci U S A; 2014 May; 111(19):7096-101. PubMed ID: 24778210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. KDM5B demethylates H3K4 to recruit XRCC1 and promote chemoresistance.
    Xu W; Zhou B; Zhao X; Zhu L; Xu J; Jiang Z; Chen D; Wei Q; Han M; Feng L; Wang S; Wang X; Zhou J; Jin H
    Int J Biol Sci; 2018; 14(9):1122-1132. PubMed ID: 29989047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel KDM5B splice variants identified in patients with developmental disorders: Functional consequences.
    Lebrun N; Mehler-Jacob C; Poirier K; Zordan C; Lacombe D; Carion N; Billuart P; Bienvenu T
    Gene; 2018 Dec; 679():305-313. PubMed ID: 30217758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemical and structural investigations clarify the substrate selectivity of the 2-oxoglutarate oxygenase JMJD6.
    Islam MS; McDonough MA; Chowdhury R; Gault J; Khan A; Pires E; Schofield CJ
    J Biol Chem; 2019 Jul; 294(30):11637-11652. PubMed ID: 31147442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 8-Substituted Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives As Potent, Cell Permeable, KDM4 (JMJD2) and KDM5 (JARID1) Histone Lysine Demethylase Inhibitors.
    Bavetsias V; Lanigan RM; Ruda GF; Atrash B; McLaughlin MG; Tumber A; Mok NY; Le Bihan YV; Dempster S; Boxall KJ; Jeganathan F; Hatch SB; Savitsky P; Velupillai S; Krojer T; England KS; Sejberg J; Thai C; Donovan A; Pal A; Scozzafava G; Bennett JM; Kawamura A; Johansson C; Szykowska A; Gileadi C; Burgess-Brown NA; von Delft F; Oppermann U; Walters Z; Shipley J; Raynaud FI; Westaway SM; Prinjha RK; Fedorov O; Burke R; Schofield CJ; Westwood IM; Bountra C; Müller S; van Montfort RL; Brennan PE; Blagg J
    J Med Chem; 2016 Feb; 59(4):1388-409. PubMed ID: 26741168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histone lysine demethylase KDM5B maintains chronic myeloid leukemia via multiple epigenetic actions.
    Xue S; Lam YM; He Z; Zheng Y; Li L; Zhang Y; Li C; Mbadhi MN; Zheng L; Cheng Z; Liu Y; Wang X; Chan LC; Ng RK; Zhang J
    Exp Hematol; 2020 Feb; 82():53-65. PubMed ID: 32007477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular architecture of the Jumonji C family histone demethylase KDM5B.
    Dorosz J; Kristensen LH; Aduri NG; Mirza O; Lousen R; Bucciarelli S; Mehta V; Sellés-Baiget S; Solbak SMØ; Bach A; Mesa P; Hernandez PA; Montoya G; Nguyen TTTN; Rand KD; Boesen T; Gajhede M
    Sci Rep; 2019 Mar; 9(1):4019. PubMed ID: 30858420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing histone demethylase inhibitors in cells: lessons learned.
    Hatch SB; Yapp C; Montenegro RC; Savitsky P; Gamble V; Tumber A; Ruda GF; Bavetsias V; Fedorov O; Atrash B; Raynaud F; Lanigan R; Carmichael L; Tomlin K; Burke R; Westaway SM; Brown JA; Prinjha RK; Martinez ED; Oppermann U; Schofield CJ; Bountra C; Kawamura A; Blagg J; Brennan PE; Rossanese O; Müller S
    Epigenetics Chromatin; 2017; 10():9. PubMed ID: 28265301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of small molecule inhibitors of Jumonji AT-rich interactive domain 1B (JARID1B) histone demethylase by a sensitive high throughput screen.
    Sayegh J; Cao J; Zou MR; Morales A; Blair LP; Norcia M; Hoyer D; Tackett AJ; Merkel JS; Yan Q
    J Biol Chem; 2013 Mar; 288(13):9408-17. PubMed ID: 23408432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lysine-241 Has a Role in Coupling 2OG Turnover with Substrate Oxidation During KDM4-Catalysed Histone Demethylation.
    Hancock RL; Abboud MI; Smart TJ; Flashman E; Kawamura A; Schofield CJ; Hopkinson RJ
    Chembiochem; 2018 May; 19(9):917-921. PubMed ID: 29443450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanistic and structural studies of KDM-catalysed demethylation of histone 1 isotype 4 at lysine 26.
    Walport LJ; Hopkinson RJ; Chowdhury R; Zhang Y; Bonnici J; Schiller R; Kawamura A; Schofield CJ
    FEBS Lett; 2018 Oct; 592(19):3264-3273. PubMed ID: 30156264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The KDM5 family of histone demethylases as targets in oncology drug discovery.
    Rasmussen PB; Staller P
    Epigenomics; 2014 Jun; 6(3):277-86. PubMed ID: 25111482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic regulation by histone demethylases in hypoxia.
    Hancock RL; Dunne K; Walport LJ; Flashman E; Kawamura A
    Epigenomics; 2015 Aug; 7(5):791-811. PubMed ID: 25832587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure and binding properties of a cameloid nanobody raised against KDM5B.
    Wiuf A; Kristensen LH; Kristensen O; Dorosz J; Jensen J; Gajhede M
    Acta Crystallogr F Struct Biol Commun; 2015 Oct; 71(Pt 10):1235-41. PubMed ID: 26457512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purification, Biochemical Analysis, and Structure Determination of JmjC Lysine Demethylases.
    Krishnan S; Trievel RC
    Methods Enzymol; 2016; 573():279-301. PubMed ID: 27372758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. KDM5B protein expressed in viable and fertile ΔARID mice exhibit no demethylase activity.
    Jamshidi S; Catchpole S; Chen J; So CWE; Burchell J; Rahman KM; Taylor-Papadimitriou J
    Int J Oncol; 2021 Nov; 59(5):. PubMed ID: 34713299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A cell-permeable ester derivative of the JmjC histone demethylase inhibitor IOX1.
    Schiller R; Scozzafava G; Tumber A; Wickens JR; Bush JT; Rai G; Lejeune C; Choi H; Yeh TL; Chan MC; Mott BT; McCullagh JS; Maloney DJ; Schofield CJ; Kawamura A
    ChemMedChem; 2014 Mar; 9(3):566-71. PubMed ID: 24504543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.